tangeretin has been researched along with Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| Alcaro, S; Ambrosio, FA; Artese, A; Bagetta, D; Catalano, R; Costa, G; Lupia, A; Maruca, A; Mesiti, F; Moraca, F; Ortuso, F; Rocca, R; Romeo, I | 1 |
| Ahmadi, Z; Ashrafizadeh, M; Ghasemipour Afshar, E; Mohammadinejad, R | 1 |
| Luqman, S; Meena, A; Raza, W | 1 |
| Al-Tel, TH; Alhamad, DW; Elgendy, SM; Omar, HA | 1 |
| Feng, SL; Liu, L; Liu, ZQ; Ma, WZ; Xie, Y; Yao, XJ; Yuan, ZW | 1 |
| De Mets, M; Mareel, MM | 1 |
5 review(s) available for tangeretin and Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
The Mediterranean Diet as source of bioactive compounds with multi-targeting anti-cancer profile.
Topics: Anticarcinogenic Agents; Antioxidants; Diet, Mediterranean; Fruit; Humans; Neoplasms; Olive Oil; Vegetables; Wine | 2019 |
Tangeretin: a mechanistic review of its pharmacological and therapeutic effects.
Topics: Animals; Anti-Inflammatory Agents; Citrus; Flavones; Flavonoids; Humans; Neoplasms; Neuroprotective Agents | 2020 |
Prospects of tangeretin as a modulator of cancer targets/pathways.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; Flavones; Humans; Neoplasms; Signal Transduction | 2020 |
Anti-invasive activities of experimental chemotherapeutic agents.
Topics: Animals; Antineoplastic Agents; Catechin; Dipyridamole; Flavones; Flavonoids; Glucosidases; Glycosylation; Humans; Lysophospholipids; Mannosidases; Mice; Microtubule Proteins; Monensin; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Pertussis Toxin; Tunicamycin; Virulence Factors, Bordetella | 1989 |
2 other study(ies) available for tangeretin and Neoplasms
| Article | Year |
|---|---|
Tangeretin as an adjuvant and chemotherapeutic sensitizer against various types of cancers: a comparative overview.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Flavones; Humans; Neoplasms | 2021 |
Tangeretin, a citrus pentamethoxyflavone, antagonizes ABCB1-mediated multidrug resistance by inhibiting its transport function.
Topics: A549 Cells; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Binding Sites; Caco-2 Cells; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flavones; G2 Phase Cell Cycle Checkpoints; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Neoplasms; Paclitaxel; Protein Binding; Protein Conformation; Structure-Activity Relationship; Taxoids; Time Factors | 2016 |